Users can run transcriptome, targeted resequencing, genotyping, and other applications all on one platform. The NextSeq 550 System offers both high- and mid-output flow cells. From large-scale to ...

It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The NextSeq 550 has been in use since 2018 and is great for mid-range projects such as ...

Both FDA-regulated and CE-in vitro diagnostic (IVD) marked, the NextSeq 550Dx instrument enables ... environment and use the full range of Illumina sequencing methods for a wide range of applications.

At a launch event on Feb. 20, Roche detailed plans to enter Illumina's sequencing stronghold with a new platform. Roche's platform is in testing now and scheduled to launch commercially in 2026.

The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...

Illumina will seek to cut $100 million ... which will include a new multimodal software platform that runs on its current NextSeq and NovaSeq hardware. The company is also developing what it ...